Tag: spironolactone

1. Cardiovascular mortality and heart failure-related hospitalization were slightly less in the steroidal MRA group, though there was no statistical ...

1. Cardiovascular mortality and heart failure-related hospitalization were similar in both groups. 2. There was no statistically significant difference between ...

1. In this randomized controlled trial, spironolactone did not significantly reduce death from cardiovascular causes or new or worsening heart ...

1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...

1. Spironolactone showed more effective improvement in acne at 12 and 24 weeks after treatment initiation as compared with the ...

1. Potassium binder therapy with patiromer can promote longer duration of spironolactone use for resistant hypertension in the setting of ...

The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, ...

1. Use of medications to inhibit the renin-angiotensin system (RAS) following transcatheter aortic valve replacement (TAVR) for severe aortic stenosis ...

1. In this meta-analysis of available randomized clinical trials, use of aldosterone antagonist therapy in patients with preserved ejection fraction ...

Image: CC/Wiki 1. There was no significant difference in the primary composite outcome (death from cardiovascular causes, aborted cardiac arrest, ...